Jeffs’ Brands: Fort Received Regulatory Approval in Germany
May 22, 2024 07:39 ET
|
Jeffs' Brands Ltd
Final approval received by tax authorities, allowing Fort to begin marketing its products in Germany Tel Aviv, Israel, May 22, 2024 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the...
Ollie’s Bargain Outlet Holdings, Inc. Announces First Quarter Fiscal 2024 Release Date and Conference Call Information
May 22, 2024 07:30 ET
|
Ollie's Bargain Outlet Holdings, Inc.
HARRISBURG, Pa., May 22, 2024 (GLOBE NEWSWIRE) -- Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) announced today that it will release its financial results for the first...
Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences
May 22, 2024 07:30 ET
|
Biogen Inc.
Transaction to include felzartamab, a potential first-in-class therapeutic candidate with promise as a pipeline-in-a-product across a range of immune-mediated diseasesFelzartamab is an investigational...
EverCommerce Announces an Increase and Extension of its Share Repurchase Program
May 22, 2024 07:30 ET
|
EverCommerce Inc.
DENVER, May 22, 2024 (GLOBE NEWSWIRE) -- EverCommerce Inc. (NASDAQ: EVCM), a leading provider of SaaS solutions for service SMBs, today announced that its Board of Directors has approved a $50...
Stock Yards Bancorp Declares Quarterly Cash Dividend of $0.30 Per Common Share
May 22, 2024 07:30 ET
|
Stock Yards Bancorp, Inc.
LOUISVILLE, Ky., May 22, 2024 (GLOBE NEWSWIRE) -- Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in the Louisville, central, eastern...
Repligen Corporation to Present at Upcoming June Investor Conferences
May 22, 2024 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be...
MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting
May 22, 2024 07:30 ET
|
MiNK Therapeutics
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of...
Anavex Life Sciences Announces Expansion of Leadership Team
May 22, 2024 07:30 ET
|
Anavex Life Sciences Corp.
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
Agrify Corporation Announces Approximately $13.8 Million Debt-to-Equity Conversion
May 22, 2024 07:30 ET
|
Agrify
Agrify Corporation Announces Approximately $13.8 Million Debt-to-Equity Conversion
BrightSpring Health Services Announces Recently Closed Acquisitions in Multiple Markets
May 22, 2024 07:30 ET
|
BrightSpring Health Services, Inc.
LOUISVILLE, Ky, May 22, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “the Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for...